Methods of synergistically improving chemotherapeutic cancer treatment and treating skin carcinoma

摘要

"METHODS OF SYNERGISTICALLY IMPROVING CHEMOTHERAPETIC TREATMENT OF CANCER AND TREATING SKIN CARCINOMA". The present invention discloses the use of high affinity Aβ3-adenosine receptor antagonists to enhance the chemotherapeutic treatment of Aβ3-adenosine cancer-expressing receptors and cancer-expressing Pglycoprotein or MRP. In preferred embodiments, the α-3- adenosine receptor antagonists are administered before or during the administration of a taxane, vinca alkaloid, camptothecin, or antibiotic chemotherapeutic agent family.